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1Central aortic hemodynamics are determined by coupling between the left ventricle and peripheral arterial tree. 
Pressure waves in the proximal aorta can be separated into a for-
ward wave traveling from the ventricle to the periphery of the 
arterial tree and a backward wave traveling in the reverse direc-
tion.1,2 The forward wave is generated primarily by ventricular 
contraction and has an amplitude that is mainly determined by 
ventricular contraction and pulse wave velocity (PWV) of the 
proximal aorta.3 The backward wave is thought to be generated 
by the reflection of the forward wave from downstream segments 
of the arterial tree and, hence, to be influenced by the characteris-
tics of the peripheral vasculature at the major sites of reflection.3 
Wave separation, therefore, potentially provides insight into the 
genesis of pulsatile components of aortic (and peripheral) blood 
pressure (BP) and, hence, into the increase in pulse pressure that 
is the major hemodynamic change contributing to hypertension 
and cardiovascular disease in the aging population.4
Most previous studies have used indirect surrogates of the 
contribution of the backward relative to the forward wave such 
as augmentation pressure (AP) or have quantified reflection 
in terms of the ratio of the peak of the forward to backward 
wave.5–7 The aim of this study was to test the hypothesis that 
increased pulse wave reflection contributes to altered backward 
waveform morphology and to increased pulse pressure in sub-
jects with higher pulse pressure compared with lower pulse 
pressure and to actions of vasoactive drugs to increase pulse 
pressure. We compared forward and backward waveform mor-
phology in subjects with low and high pulse pressure and after 
changes in pulse pressures induced by a range of inotropic, 
vasoconstrictor and vasodilator drugs. We used numeric mod-
eling to confirm the interpretation of the experimental results.
Methods
Study 1: Central Hemodynamics in Patients With 
Hypertension
Subjects (n=158, 81 male, aged 46±17 years, mean±SD) were 
recruited from those who were evaluated for hypertension at Guy’s 
and St Thomas’ Hypertension Clinic. Although subjects were 
referred for evaluation of hypertension, BP settled in some subjects 
and the sample included some who were normotensive; 48% of the 
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subjects were on treatment. Subjects with significant valvular disease, 
impaired left ventricular systolic function (ejection fraction <45%), 
and arrhythmias were excluded. The sample included a subsample of 
20 subjects in which we have previously published data on hemody-
namics (but not with the present focus on waveform morphology).8 
Anthropometric and clinical data were collected on the day of the 
research investigations, including height, weight, measurements of 
systolic and diastolic BP, and the characteristics of hypertensive sub-
jects and are shown in Table. Patients were divided into 3 groups 
corresponding to tertiles of central pulse pressure (group 1, 33±6.5 
mm Hg; group 2, 45±4.1 mm Hg; and group 3, 64±12.9 mm Hg, 
means±SD) to test the hypothesis that reflection and backward wave-
form morphology contribute to raised pulse pressure. Hemodynamic 
measurements were obtained as detailed below.
Study 2: Effects of Dobutamine, Norepinephrine, 
Phentolamine, and Nitroglycerin, on Central 
Hemodynamics in Normotensive Volunteers
Healthy volunteers (n=13, 10 male, aged 47±10 years, mean±SD) 
took part in crossover studies to investigate the change in pulsatile 
hemodynamics during administration of drugs with different inotro-
pic and vasopressor/vasodilator properties: dobutamine (a positive 
inotrope with some vasodilator actions), norepinephrine (a vasocon-
strictor with some inotropic actions), phentolamine (a small artery 
dilator), and nitroglycerin (predominantly a large artery dilator with 
some action on ventricular dynamics and also venodilation). Each 
subject received at least 2 comparator drugs: either the vasopressor 
agents dobutamine and norepinephrine or the vasodilators phentol-
amine and nitroglycerin, and data for each drug were obtained on 
at least 10 subjects. Each drug was given on a different occasion 
separated by at least 7 days, and the order was randomized. Some 
hemodynamic data on norepinephrine and dobutamine have previ-
ously been published (but not with the present focus on waveform 
morphology).8 Measurements were performed in a quiet temperature 
controlled (24–26°C) vascular laboratory, and subjects were asked to 
avoid caffeine and alcohol on the day of the study. On arrival in the 
vascular laboratory, a peripheral venous catheter was inserted into the 
left antecubital fossa through which 0.9% saline (Baxter Healthcare) 
vehicle or drugs dissolved in saline were infused at 1 mL/min using 
a syringe driver (Injectomat, Agilia; Fresenius Kabi, Bad Homburg 
vor der Höhe, Germany). After 30-minute resting supine during infu-
sion of saline vehicle, baseline hemodynamic measurements were 
made as detailed below. On different occasions, dobutamine (2.5, 
5, and 7.5 µg/kg per minute; Hameln Pharmaceuticals, Gloucester, 
United Kingdom), norepinephrine (12.5, 25, and 50 ng/kg per min-
ute; Aguettant, Bristol, United Kingdom), phentolamine (1 mg 
bolus+25 μg/min, 2 mg+50 μg/min, and 4 mg+100 μg/min; Alliance 
Pharmaceuticals, Chippenham, United Kingdom), and nitroglycerin 
(3, 10, and 30 μg/min; Hospira Incorporation, Lake Forest, IL) dis-
solved in 0.9% saline vehicle were then infused at 1 mL/min, and 
hemodynamic measurements were repeated at each drug dose when 
steady state was achieved after at least 7 minutes of infusion. Both 
studies 1 and 2 were approved by the London Westminster Research 
Ethics Committee, and written informed consent was obtained.
Hemodynamic Measurements
Hemodynamic measurements were performed as previously 
described.8 Radial and carotid pressure waveforms were obtained by 
applanation tonometry performed by an experienced operator using 
the SphygmoCor system (AtCor, West Ryde, New South Wales, 
Australia). Approximately 10 cardiac cycles were obtained and 
ensemble averaged. Waveforms that did not meet the in-built quality 
control criteria in the SphygmoCor system were rejected. Brachial 
BP was measured in triplicate by a validated oscillometric method 
(Omron 705CP; Omron Healthcare, Japan) and used to calibrate 
radial waveforms and thus to obtain a mean arterial pressure through 
integration of the radial waveform. Carotid waveforms were cali-
brated from mean arterial pressure and diastolic brachial BP on the 
assumption of equality of these pressures at central and peripheral 
sites.9 Ultrasound imaging was performed by an experienced operator 
using the Vivid-7 ultrasound platform (General Electric Healthcare, 
Little Chalfont, United Kingdom). Velocity above the aortic valve 
was recorded using pulsed wave Doppler obtained from an apical 
5-chamber view. All ultrasound measurements were averaged over at 
least 3 cardiac cycles.
Waveform Postprocessing
Ensemble averaged carotid pressure was used as surrogate for ascend-
ing aortic pressure.10 This together with aortic flow velocity was 
processed offline using custom software in MATLAB (MathWorks, 
Natick, MA) for wave separation analysis. The first systolic shoul-
der/peak (P1) of the aortic pressure waveform was identified as the 
first local minimum of the first derivative of the pressure curve (and 
confirmed by visual inspection by an observer blinded to the results) 
to determine the pulsatile component of BP at P1 (Figure 1) and aug-
mentation pressure (AP, the difference between pressure at the second 
systolic peak, P2, and that at the first shoulder/peak). Wave decom-
position was based on the conservation of mass and momentum and 
performed using Parker’s time-domain approach2 to obtain forward 
(Pf) and backward (Pb) pressure components of central pulse pressure 
so that Pf+Pb=P−Pd, where P is total pressure and Pd is the diastolic 
pressure. Pf and Pb are given by










Table.  Characteristics of Hypertensive Subjects
Characteristic
Pulse Pressure Groups
P Value1, n=53 2, n=53 3, n=52
Age, y 38.9±14.7 44.7±13.8 55.3±16.9 <0.001
Sex, male, % 43 64 46 0.091
BMI, kg/m2 26.6±4.38 27.1±4.10 27.1±4.64 0.77
Drug therapy
  ACEI, % 2 18 24 0.01
  ARB, % 6 8 9 0.88
  β-Blocker, % 6 10 20 0.11
  Calcium channel 
blocker, %
21 24 24 0.89
  Diuretic, % 4 6 11 0.41
  α-Blocker, % 6 6 16 0.20
HR, bpm 66.3±1.3 64.4±1.5 65.6±1.5 0.65
pSBP, mm Hg 122.4±1.92 135.0±1.68 157.5±2.80 <0.001
DBP, mm Hg 78.7±1.6 82.5±1.5 86.1±2.1 0.012
cSBP, mm Hg 111.4±2.0 127.5±1.6 149.9±2.9 <0.001
cPP, mm Hg 32.6±0.9 45.0±0.6 63.7±1.8 <0.001
AP, mm Hg −0.81±1.0 1.85±1.3 11.0±1.6 <0.001
AIx −1.56±2.7 5.11±2.7 16.6±2.3 <0.001
PWV, m/s 3.91±0.15 5.12±0.17 6.60±0.24 <0.001
U
max
, m/s 1.11±0.024 1.15±0.032 1.19±0.034 0.15
Age and BMI are shown as mean±SD; other results are shown as mean±SE. 
ACEI indicates angiotensin-converting enzyme inhibitor; AIx, augmentation 
index; AP, augmentation pressure; ARB, angiotensin receptor blocker; BMI, body 
mass index; cPP, central pulse pressure; cSBP, central systolic blood pressure; 
DBP, diastolic blood pressure; HR, heart rate; pSBP, peripheral systolic blood 
pressure; PWV, pulse wave velocity; and U
max
, maximum flow velocity.
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where U is flow velocity, ρ is blood density, and c is PWV, which was 
calculated using the method of the sum of squares.11
Waveform Timing and Morphology
The time of arrival of the backward wave (T
abR) relative to the forward 
wave was measured as a proportion of the total period of the pressure 
pulse (T). Dimensionless parameters were used to describe the morphol-
ogy of the backward wave relative to that of the forward wave (Figure 1): 
peak time ratio (TPR), the ratio of time from the start of systole to the peak 
of backward wave (TPb) to that of the peak of forward wave (TPf); reflec-
tion coefficient for peak values (amplitudes) of forward and backward 
waves (RCp), the ratio of the peak value of the backward wave (Pb) to 
that of the forward wave (Pf); peak slope ratio, the ratio of the maximum 
slope of the upstroke of the backward wave (Sb, measured over the range 
20%–80% of its peak value) to that of the forward wave (Sf); area ratio, 
the ratio of area under backward wave (Ab) to the area under forward 
wave (Af); and width ratio, the ratio of width at 80% of peak value of the 
backward wave (Wb) to that of the forward wave (Wf). A graphical com-
parison of relative waveform morphology between groups and effects 
of drugs on relative waveform morphology was made by calculating a 
scaling factor at each point in the cardiac cycle for height of the backward 
wave relative to the forward wave in one group or intervention (drug 
versus control) and then applying this to the other group or intervention.
Numeric Modeling
A previously described 55-segment model that, for a given prescribed 
aortic flow, generates physiological aortic pulse waveforms12 was used 
for numeric simulations. Each artery of the network is characterized by 
its diameter, length, wall thickness, and arterial wall stiffness. The periph-
eral branches of the model are coupled to 3-element Windkessel models 
that represent the resistive and capacitive effects of the distal vessels. For 
the purpose of this study, a virtual database of 3325 healthy adult subjects 
with cardiac and arterial parameters spanning the physiological range13 
was used to study the relationship between forward and backward waves. 
The parameters varied included heart rate, stroke volume, the stiffness, 
and diameter of elastic and muscular conduit arteries and peripheral resis-
tances. Because some combinations of these parameters result in non-
physiological features of the aortic pulse, combinations were restricted 
to those that generated a BP (at the brachial artery) with diastolic pres-
sure >40 mm Hg, systolic pressure <200 mm Hg, and pulse pressure >25 
and <100 mm Hg.
Statistics
A sample size of >150 was calculated to give >80% power (P<0.05) to 
detect a difference in reflection coefficient of >0.06 (≈20% of a typical 
value of 0.3) for subjects in the lowest and highest tertiles of pulse pres-
sure. Subject characteristics are presented as means±SD, and results 
are as means±SE. Comparison of subject characteristics across tertiles 
of pulse pressure was made by one-way analysis of variance or (for cat-
egorical variables) by χ2 test. Differences in hemodynamic character-
istics across tertiles of pulse pressure were also sought using one-way 
analysis of variance. Effects of drugs were examined using analysis of 
variance for repeated measures. Analysis was performed using SPSS 
version 19 and P value <0.05 was taken as significant. Ninety-five per-
cent confidence intervals were calculated for key negative results.
Results
Central Hemodynamics in Patients With 
Hypertension
Compared with subjects in group 1, subjects in group 3 were 
characterized by increased central aortic pulsatility with mean 
values of P1, P2, and AP greater than those in group 1 by 
21.0±2.5, 32.8±3.1, and 11.8±1.6 mm Hg, respectively. P1 
and P2 were of approximately equal magnitude in group 1, 
so that AP was close to zero. However, in groups 2 and 3, P2 
exceeded P1 with an AP of 11.0±1.6 mm Hg in group 3, and in 
most subjects, central pulse pressure was equal to P2.
Wave separation analysis demonstrated that, in group 
1, both P1 and P2 were determined mainly by the for-
ward wave, although, in subjects with a positive AP, the 
backward wave did contribute to P2 (Figure 2A and 2C). 
In group 3 (in which AP was positive, Figure 2D), P1 was 
also determined by the forward component of the pressure 
wave, and the forward wave provided the major contribu-
tion to P2. However, the backward wave provided a greater 
contribution to P2 than in group 1 (8.73±1.05 compared 
with 2.34±0.68 mm Hg in group 1, P<0.01; Figure 2) and 
contributed 7.84±1.15 mm Hg to the total AP of 11.0±1.60 
mm Hg in group 3 (Figure 2D). Thus, the backward wave 
provided a slightly greater contribution to central pulse pres-
sure in group 3 compared with group 1: 12.9±1.4% versus 
7.49±1.3%; Figure 2C). The contribution of the backward 
wave relative to the forward wave increased over the cardiac 
cycle, so that its contribution to end-systolic pressure (P
es
) 
was greater than to P1 or P2 (Figure 2B).
A B
Figure 1. A, Central aortic pressure waveform showing the height above diastolic pressure of the first systolic shoulder (P1) and 
augmentation pressure (AP). Also shown are the forward (dashed line) and backward (dotted line) waves that summate to equal total 
pressure (solid line). B, Definition of wave morphology. TabR, the time of arrival of the backward wave relative to the forward wave was 
measured as a proportion of the total period of the pressure pulse (T). Dimensionless parameters were used to describe the morphology 
of the backward wave relative to that of the forward wave: TPR, the ratio of time (from the start of systole) to the peak of backward wave 
(TPb) to that of the peak of forward wave (TPf); RCp, the ratio of the peak value of backward wave (Pb) to that of the forward wave (Pf); SR, the 
ratio of the maximum slope of the upstroke of the backward wave (Sb, measured over the range 20%–80% of its peak value) to that of the 
forward wave (Sf); WR, the ratio of width at 80% of peak value of the backward wave (Wb) to that of the forward wave (Wf); and AR, the ratio 
of area under backward wave (Ab) to the area under forward wave (Af). AR indicates area ratio.
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The backward wave arrived earlier in subjects in group 3 
compared with those in group 1 (95±0.4 versus 109±5.4 ms, 
P<0.05). However, the morphology of the backward wave rela-
tive to the forward wave was similar across the pulse pressure 
groups with no significant difference between RCp and the ratios, 
slope ratio, width ratio, and area ratio, relating to the relative 
upslope, width at 80% of peak height, and areas across the pulse 
pressure groups (Table S1 in the online-only Data Supplement). 
The similarity of waveform morphology is depicted in Figure 3 
in which the backward wave for group 3 is derived by applying 
a scaling factor to the forward wave in group 3 that is derived 
from the relative height of the backward to forward waves in 
group 1 (ie, a reflection coefficient calculated at each point in 
the cardiac cycle rather than from the peaks of backward and 
forward waves). The backward wave derived from the group 1 
scaling factor is close to identical to that of the observed back-
ward wave in group 3. The mean difference of reflection coef-
ficient between these groups (mean for group 1−mean for group 
3) was 0.004 with 95% confidence intervals of −0.040 to +0.049.
Effects of Dobutamine, Norepinephrine, 
Phentolamine, and Nitroglycerin, on Central 
Hemodynamics in Normotensive Volunteers
Hemodynamic changes during inotropic/vasopressor and vaso-
dilator stimulation are summarized in the Table S2. Changes in 
pulsatile and mean components of BP were as expected from 
the pharmacology of the drugs. Dobutamine with inotropic and 
vasodilator properties increased pulsatility (P1 and P2) but had 
no significant effect on diastolic BP. Norepinephrine increased 
diastolic BP and P2. Phentolamine decreased diastolic BP but 
had no significant effect on pulsatility. Nitroglycerin (NTG) 
decreased diastolic BP and P2. Dobutamine increased PWV, 
but the other drugs did not significantly influence PWV. RCp 
decreased from 0.26±0.018 to 0.19±0.019 (P<0.01) during infu-
sion of nitroglycerin. However, for all of the other drugs, RCp 
remained similar at baseline and during drug infusion (mean dif-
ferences [95% confidence interval] from baseline: 0.02 [−0.018 
to 0.058], 0.01 [−0.047 to 0.067], and −0.001 [−0.035 to 0.033] 
for dobutamine, norepinephrine, and phentolamine, respectively. 
All other waveform morphology parameters also remained simi-
lar at baseline and during drug infusion (Figure 4; Table S3).
Numeric Modeling
Amplitude of the forward wave (Pf) was mainly determined 
by the product of proximal aortic PWV and aortic flow veloc-
ity (Figure 5A; R=0.992, P<0.001 for the relation between 
forward wave amplitude and the PWV and aortic flow velocity 
product) with PWV and flow velocity accounting for approxi-
mately equal amounts of variance in Pf (Figure 5B). For the 
whole virtual database, the amplitude of the backward wave 
A B
C D
Figure 2. Pressure pulse components 
showing total pressure pulse and forward 
(FPW) component of pressure pulse for 
(A) first systolic peak (P1); (B) end-systolic 
pressure (Pes); (C) second systolic peak 
(P2); and (D) augmentation pressure (AP).
A B
Figure 3. Average plots of pressure 
components in (A) group 1 and (B) group 
3, showing measured pressure (solid 
line), forward pressure (dashed line), and 
backward pressure (dotted line). Grey 
solid line shows the backward wave 
calculated using the ratio of the backward 
to forward wave (at each point in the 
cardiac cycle) in group 1 (ie, assuming a 
constant backward/forward ratio at each 
point in the cardiac cycle).
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(Pb) bore an approximately constant relationship to that of the 
forward wave (Figure 5C; R=0.931, P<0.001). However, when 
the compliance of muscular conduit arteries was varied inde-
pendently from that of the aorta, the amplitude of the back-
ward wave was seen to vary independently from that of the 
forward wave (Figure 5D), accounting for the relatively small 
amount of scatter around the regression line relating backward 
to forward wave amplitude in the whole virtual database.
Discussion
Contribution of Reflection and Backward Wave 
Morphology to Pulse Pressure in Hypertension
A major finding of this study is that, for different levels of 
pulse pressure, morphology of the backward pressure wave 
bears a constant relationship to that of the forward wave. Thus, 
a reflection coefficient defined as the ratio of the maximum 
height (amplitude) of the backward pressure wave to that of 
the forward wave or of the relative heights of each wave at 
any point throughout the cardiac cycle is constant across ter-
tiles of pulse pressure. Although the backward wave is greater 
in those with high pulse pressure compared with low pulse 
pressure, its contribution to total pressure early in systole is 
relatively modest and, at any point in the cardiac cycle, it is 
proportionate to that of the forward wave. Thus, the forward 
wave is the dominant determinant of pulse pressure, and the 
amount of reflection as measured from the ratio of backward 
to forward wave does not play a major role in contributing to 
a raised pulse pressure in hypertension. Earlier arrival of the 
backward wave was observed in subjects with greater pulse 
pressure, but this led to only a minor increase in contribution 
of the backward wave relative to the forward wave.
Contribution of Reflection and Backward Wave 
Morphology to Change in Pulse Pressure Generated 
by Vasoactive Drugs
We also observed similar morphology of the backward relative 
to the forward wave when comparing drugs that act mainly to 
increase myocardial contractility, constrict peripheral resis-
tance vessels (norepinephrine), and dilate peripheral resis-
tance vessels (phentolamine). Thus, despite wide perturbation 
of ventricular dynamics and peripheral resistance, reflection 
coefficient remained constant. The predominant action of 
these drugs is to increase myocardial contractility with some 
peripheral vasodilation (dobutamine), constrict peripheral 
resistance vessels with some increase in myocardial contrac-
tility (norepinephrine), and dilate peripheral resistance vessels 
(phentolamine). The exception to this was NTG, which has a 
specific action to dilate muscular conduit arteries.14 NTG pro-
duced a significant reduction in reflection so that the backward 
wave was reduced relative to the forward wave. This occurred 
in the absence of any change in PWV and confirms that selec-
tive modulation of muscular conduit vessel tone can influence 
the amount of reflection as previously suggested.15,16
Comparison of Experimental Results With Numeric 
Modeling Approach
Although the theory of wave separation invokes few assump-
tions, being dependent on basic physical principles of conserva-
tion of mass and momentum, it is subject to experimental error 
A B
C D
Figure 4. Measured pressure wave (black solid line) and decomposed forward (black dashed line) and backward (black dotted line) waves 
of the highest dose of (A) dobutamine (DB); (B) norepinephrine (NE); (C) phentolamine (PHT); and (D) nitroglycerin (NTG). The grey line is 
the backward wave calculated by applying the backward/forward ratio at baseline (at each point during the cardiac cycle) to the forward 
wave during drug infusion (ie, by assuming a constant backward/forward ratio at each point in the cardiac cycle).
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in determining aortic flow velocity and estimating aortic pressure 
from carotid tonometry. A complimentary approach, therefore, 
is to use a numeric simulation.12 This removes experimental 
error but is dependent on the accuracy of the numeric model and 
parameters assigned to the elements of the model. Using a real-
istic model and with a wide range of parameters spanning the 
physiological range,13 we obtained results that were entirely con-
sistent with the experimental results. Thus, the amplitude of the 
forward wave was determined by ventricular dynamics and aortic 
PWV, and the backward wave was proportional to the forward 
wave but with some variance. This variance of the amplitude of 
the backward wave relative to that of the forward wave (ie, vari-
ance in reflection) was explained by variation in the compliance 
of muscular conduit arteries, which would be compatible with 
the observed experimental influence of NTG on reflection. Taken 
together, our experimental results in patients with hypertension, 
in normotensive subjects under the influence of inotropic, vaso-
pressor and vasodilator drugs, and theoretical numeric simula-
tions, strongly support previous findings that the forward wave 
is the dominant determinant of pulsatile components of BP early 
in the systole.8
Limitations
We studied predominantly middle-aged subjects with hyperten-
sion, who were on treatment, and it is possible that, within the 
general population, the contribution of reflection to the age-related 
increase in pulse pressure is more important than in essential 
hypertension; our conclusions may not be valid in untreated 
subjects. In a large community-based study, Torjesen et al17 have 
shown amount of reflection as assessed by reflection coefficient 
to be an important determinant of AP which, in turn, contributes 
a relatively large proportion of the age-related increase in pulse 
pressure, especially in middle-aged women.18 Even within the 
study of Torjesen et al,17 however, there was much greater varia-
tion of the forward wave compared with that of the backward 
wave over the lifespan, with forward wave amplitude varying, on 
average, by ≈30 mm Hg from the third to ninth decade and with 
reflection approximately constant to within 15%.
Perspectives
The characteristics of ventricular-vascular coupling, particularly 
pressure wave reflection and the contribution of the backward 
pressure wave to BP, are controversial. Previous studies have 
assessed reflection indirectly assuming AP or index to be a mea-
sure of reflection or have quantified reflection using a single mea-
sure of the ratio of the peak backward to forward wave. Here, we 
measure the ratio of backward to forward pressure over the whole 
of the cardiac cycle and find it to be largely invariant of pulse 
pressure or of modulation of cardiovascular function with inotro-
pic, vasopressor or vasodilator drugs. These observations together 
with studies showing the dominance of the forward wave during 
exercise19 underline the importance of ventricular dynamics and 
proximal aortic PWV as the major determinants of physiologi-
cal and pathophysiological variation in pulse pressure. Reflection 
A B
C D
Figure 5. The relation of forward pressure wave amplitude (Pf) to pulse wave velocity (PWV) and the relation of backward pressure wave 
amplitude (Pb) to Pf as predicted by a 55-element branched arterial model. A, Relation between Pf and the product of PWV and aortic 
flow velocity (U) for the whole population. B, Relation between Pf and PWV when stroke volume (and hence U) is varied in discrete steps: 
−20% (○), 0% (● ), and +20% (∆) of the median and other arterial properties held constant. C, Relation between Pb and Pf for the whole 
virtual population of 3325 subjects with arterial properties spanning the physiological range. D, Relation between Pb and Pf for the same 
range of values of large artery elastic modulus as in C, but variation of elastic modulus of muscular arteries is varied in discrete steps: 
−20% (○), 0% (● ), +15% (∆), and +30% (■) of the median and other arterial properties held constant. This demonstrates that the scatter 
around the regression line in C stems mainly from variation in elastic modulus of muscular arteries.
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can be modulated by NTG, which has a specific action to dilate 
muscular conduit arteries; although increased muscular conduit 
artery tone is unlikely to contribute significantly to pulse pressure 
in hypertension, organic nitrates may be an effective treatment 
for reducing central pulse pressure both through a reduction in 
reflection and through a direct action on ventricular dynamics.20
Conclusions
The ratio of backward to forward central aortic pressure 
remains approximately constant across groups with differ-
ing pulse pressure. Therefore, increased reflection is unlikely 
to contribute to increased pulse pressure in hypertension. 
However, the amount of reflection can be reduced by selective 
dilation of muscular arteries.
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What Is New?
•	This is the first study to examine the ratio of backward to forward central 
pressure throughout the cardiac cycle.
What Is Relevant?
•	Our finding of a constant ratio of backward to forward pressure across 
hypertensive groups with a 2-fold difference in pulse pressure and in 
normotensive subjects in the presence of inotropic, vasopressor and va-
sodilator stimulation suggests that variation in the amount of reflection 
contributes little to that of pulsatile components of blood pressure. How-
ever, reflection can be reduced by selective dilation of muscular arteries, 
and this may be an effective treatment to reduce central pulse pressure.
Summary
Increased reflection as measured by backward/forward wave ratio 
contributes little to raised pulse pressure in hypertension but can 
be modified by dilation of peripheral muscular arteries.
Novelty and Significance
